43
Interference Studies
Interference studies were performed according to CLSI
Document EP7-A2. The following substances have not
been found to interfere with the HemoCue WBC system.
The highest concentration or percentages tested is
referred to in brackets.
Acetaminophen (20 mg/dL), ascorbic acid (6 mg/dL),
ibuprofen (50 mg/dL), caffeine (308 µmol/L), creatinine/
urea (30 mg/dL/500 mg/dL), salicylic acid (60 mg/dL),
tetracycline (30 mg/dL), unconjugated bilirubin
(342 µmol/L), conjugated bilirubin (380 µmol/L), dex-
tran 40 (30 g/L), osmolality (167 mmol/L), HbCO (30 %),
methemoglobin (50 %), thrombocytes (2000 x10
9
g/L),
lipemia (intralipid 3100 mg/L) which corresponds to
triglycerides (approximately 10.5 mmol/L), hemoglobin
(30–250 g/L), reticylocytes (258 x10
9
L), HbAS, immature
leukocytes and platelet clumping have not been found
to interfere. pH values between 6.8–8.0 do not interfere
with the system.
Technical Specifications
Dimensions: 179 x 133 x 121 mm (7.05 x 5.24 x 4.76 inches)
Weight: 600 g (1.32 pounds) (with 6 AA batteries in-
stalled)
Power adapter: CE marked
Only use adapters, as listed under Adapters.
Pollution degree: 2
Overvoltage category: II
Atmospheric pressure: 700 hPa to 1060 hPa.
Equipment not suitable for use in the presence of flam-
mable mixtures.
The HemoCue WBC system has been tested for electrical
safety and EMC according to the following standards:
• IEC/EN 61010-2-101, 2002 (First Edition), IEC 61010-1,
2001 (Second Edition) and EN 61010-1, CAN/CSA-C22.2
no.61010-1, 2004 (Second Edition), UL 61010-1, 2004
(Second Edition), IEC 60601-1-2:2007 (Third Edition)
and EN 60601-1-2:2007, IEC 61326-1:2005 and EN 61326-
1:2006, and IEC 61326-2-6:2005 (First Edition) and EN
61326-2-6:2006
Essential Performance
The HemoCue WBC system is an
In-Vitro diagnostic
system designed for quantitative determination of white
blood cells (WBC) in capillary or venous whole blood.
Recommended separation distance between Portable
and mobile RF communications equipment and
HemoCue WBC Analyzer
The HemoCue systems are intended for use in an electro-
magnetic environment in which radiated RF disturbances
are controlled. The customer or the user of HemoCue
systems can help prevent electromagnetic interference
by maintaining a minimum distance between portable
and RF communications equipment (transmitters) and
HemoCue systems as recommended below, according
to the maximum output power of the communications
equipment.
Содержание WBC
Страница 1: ...HemoCue WBC Operating Manual Manuel d utilisation ...
Страница 2: ......
Страница 4: ......
Страница 6: ...HemoCue CleanerWBC 3 2 1 4 5 6 6 Components Éléments ...
Страница 8: ...1 2 3 8 Start up Mise en service ...
Страница 10: ...4 5 6 7 4 10 ...
Страница 12: ...1 2 3 12 Set up Audio signal Configuration Signal sonore ...
Страница 14: ...1 2 4 3 14 Measuring Capillary blood Mesure Sang capillaire ...
Страница 16: ...5 7 6 8 16 ...
Страница 18: ...10 9 11 18 ...
Страница 20: ...12a 12b 13 14 15 20 ...
Страница 22: ...1 2 2 3 22 Measuring Control material or venous blood Mesure Solution de contrôle ou sang veineux ...
Страница 24: ...1 2 3 24 Set up Printer function Configuration Mode impression ...
Страница 26: ...1 2 3 4 5 26 Maintenance Daily Maintenance Entretien Entretien quotidien ...
Страница 28: ...1 2a 2b 3 4 28 Maintenance Optical Parts Entretien Pièces optiques ...
Страница 66: ...66 ...
Страница 67: ...67 ...